235 related articles for article (PubMed ID: 33947539)
1. Oral administration co-delivery nanoparticles of docetaxel and bevacizumab for improving intestinal absorption and enhancing anticancer activity.
Feng QP; Zhu YT; Yuan YZ; Li WJ; Yu HH; Hu MY; Xiang SY; Yu SQ
Mater Sci Eng C Mater Biol Appl; 2021 May; 124():112039. PubMed ID: 33947539
[TBL] [Abstract][Full Text] [Related]
2. Glioblastoma multiforme targeted delivery of docetaxel using bevacizumab-modified nanostructured lipid carriers impair in vitro cell growth and in vivo tumor progression.
Di Filippo LD; Lobato Duarte J; Hofstätter Azambuja J; Isler Mancuso R; Tavares Luiz M; Hugo Sousa Araújo V; Delbone Figueiredo I; Barretto-de-Souza L; Miguel Sábio R; Sasso-Cerri E; Martins Baviera A; Crestani CC; Teresinha Ollala Saad S; Chorilli M
Int J Pharm; 2022 Apr; 618():121682. PubMed ID: 35307470
[TBL] [Abstract][Full Text] [Related]
3. The efficiency and mechanism of a new absorption enhancer, malic acid, for enhancing the oral bioavailability of docetaxel.
Guo XH; Ding F; Lian X; Cui W; Li Z; Xing Y
Pharm Dev Technol; 2021 Jun; 26(5):592-598. PubMed ID: 33734909
[TBL] [Abstract][Full Text] [Related]
4. Uniform carboxymethyl chitosan-enveloped Pluronic F68/poly(lactic-co-glycolic acid) nano-vehicles for facilitated oral delivery of gefitinib, a poorly soluble antitumor compound.
Wang J; Wang F; Li X; Zhou Y; Wang H; Zhang Y
Colloids Surf B Biointerfaces; 2019 May; 177():425-432. PubMed ID: 30798063
[TBL] [Abstract][Full Text] [Related]
5. Preparation and characterization of surface-modified PLGA-polymeric nanoparticles used to target treatment of intestinal cancer.
Ahmad N; Alam MA; Ahmad R; Naqvi AA; Ahmad FJ
Artif Cells Nanomed Biotechnol; 2018 Mar; 46(2):432-446. PubMed ID: 28503995
[TBL] [Abstract][Full Text] [Related]
6. Binary blended co-delivery nanoparticles with the characteristics of precise pH-responsive acting on tumor microenvironment.
Ye C; Li WJ; Yu HH; Feng QP; Wu X; Zhu YT; Hu MY; Xiang SY; Yu SQ
Mater Sci Eng C Mater Biol Appl; 2020 Dec; 117():111370. PubMed ID: 32919698
[TBL] [Abstract][Full Text] [Related]
7. Novel docetaxel chitosan-coated PLGA/PCL nanoparticles with magnified cytotoxicity and bioavailability.
Badran MM; Alomrani AH; Harisa GI; Ashour AE; Kumar A; Yassin AE
Biomed Pharmacother; 2018 Oct; 106():1461-1468. PubMed ID: 30119220
[TBL] [Abstract][Full Text] [Related]
8. Nanoparticles from Gantrez® AN-poly(ethylene glycol) conjugates as carriers for oral delivery of docetaxel.
Ruiz-Gatón L; Espuelas S; Huarte J; Larrañeta E; Martin-Arbella N; Irache JM
Int J Pharm; 2019 Nov; 571():118699. PubMed ID: 31536764
[TBL] [Abstract][Full Text] [Related]
9. Folate-Functionalized Thiomeric Nanoparticles for Enhanced Docetaxel Cytotoxicity and Improved Oral Bioavailability.
Sajjad M; Khan MI; Naveed S; Ijaz S; Qureshi OS; Raza SA; Shahnaz G; Sohail MF
AAPS PharmSciTech; 2019 Jan; 20(2):81. PubMed ID: 30645705
[TBL] [Abstract][Full Text] [Related]
10. Dipeptide-modified nanoparticles to facilitate oral docetaxel delivery: new insights into PepT1-mediated targeting strategy.
Du Y; Tian C; Wang M; Huang D; Wei W; Liu Y; Li L; Sun B; Kou L; Kan Q; Liu K; Luo C; Sun J; He Z
Drug Deliv; 2018 Nov; 25(1):1403-1413. PubMed ID: 29890854
[TBL] [Abstract][Full Text] [Related]
11. Multifunctional pH-Responsive Folate Receptor Mediated Polymer Nanoparticles for Drug Delivery.
Cai X; Yang X; Wang F; Zhang C; Sun D; Zhai G
J Biomed Nanotechnol; 2016 Jul; 12(7):1453-62. PubMed ID: 29337470
[TBL] [Abstract][Full Text] [Related]
12. Development of conjugate-by-conjugate structured nanoparticles for oral delivery of docetaxel.
Ha-Lien Tran P; Wang T; Yang C; Tran TTD; Duan W
Mater Sci Eng C Mater Biol Appl; 2020 Feb; 107():110346. PubMed ID: 31761193
[TBL] [Abstract][Full Text] [Related]
13. Preparation of Deoxycholate-Modified Docetaxel-Cimetidine Complex Chitosan Nanoparticles to Improve Oral Bioavailability.
Xu Y; Fang T; Yang Y; Sun L; Shen Q
AAPS PharmSciTech; 2019 Sep; 20(7):302. PubMed ID: 31489504
[TBL] [Abstract][Full Text] [Related]
14. Docetaxel-loaded PAMAM-based poly (γ-benzyl-l-glutamate)-b-d-α-tocopheryl polyethylene glycol 1000 succinate nanoparticles in human breast cancer and human cervical cancer therapy.
Wang Y; Zuo A; Huang X; Ying Y; Shu X; Chen X; Yang Y; Ma J; Lin G; Wang X; Mei L; Liu G; Zhao Y
J Microencapsul; 2019 Sep; 36(6):552-565. PubMed ID: 31403342
[TBL] [Abstract][Full Text] [Related]
15. Co-delivery of Docetaxel and Disulfonate Tetraphenyl Chlorin in One Nanoparticle Produces Strong Synergism between Chemo- and Photodynamic Therapy in Drug-Sensitive and -Resistant Cancer Cells.
Gaio E; Conte C; Esposito D; Miotto G; Quaglia F; Moret F; Reddi E
Mol Pharm; 2018 Oct; 15(10):4599-4611. PubMed ID: 30148955
[TBL] [Abstract][Full Text] [Related]
16. Enhanced antitumor efficacy of bile acid-lipid complex-anchored docetaxel nanoemulsion via oral metronomic scheduling.
Jha SK; Chung JY; Pangeni R; Choi HS; Subedi L; Kweon S; Choi JU; Byun Y; Kim YH; Park JW
J Control Release; 2020 Dec; 328():368-394. PubMed ID: 32890552
[TBL] [Abstract][Full Text] [Related]
17. Sulfobutylether-β-cyclodextrin/chitosan nanoparticles enhance the oral permeability and bioavailability of docetaxel.
Wu J; Shen Q; Fang L
Drug Dev Ind Pharm; 2013 Jul; 39(7):1010-9. PubMed ID: 22681515
[TBL] [Abstract][Full Text] [Related]
18. Development and Characterization of a Fucoidan-Based Drug Delivery System by Using Hydrophilic Anticancer Polysaccharides to Simultaneously Deliver Hydrophobic Anticancer Drugs.
Lai YH; Chiang CS; Hsu CH; Cheng HW; Chen SY
Biomolecules; 2020 Jun; 10(7):. PubMed ID: 32605162
[TBL] [Abstract][Full Text] [Related]
19. Co-delivery of chemotherapeutic drugs with vitamin E TPGS by porous PLGA nanoparticles for enhanced chemotherapy against multi-drug resistance.
Zhu H; Chen H; Zeng X; Wang Z; Zhang X; Wu Y; Gao Y; Zhang J; Liu K; Liu R; Cai L; Mei L; Feng SS
Biomaterials; 2014 Feb; 35(7):2391-400. PubMed ID: 24360574
[TBL] [Abstract][Full Text] [Related]
20. Drug-interactive mPEG-
Gong F; Wang R; Zhu Z; Duan J; Teng X; Cui ZK
Drug Deliv; 2020 Dec; 27(1):238-247. PubMed ID: 32003299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
